Y. Banz

Discipline

Sciences de l'information et de la communication (1)

Type de document

Articles (7)

Co-auteur

Date

Source

Mot-clé

Patients (5) Patients (5) maladie (4) maladie (4) pathologie (3) abords (agglomération) (3) Pathology (3) Human beings (3) Lymphomas (3) Expression (3) spectacle (2) famille (2) différenciation (2) dommage (2) survie (2) Differentiation (2) Case (2) Control (2) Cases (2) Survival (2) Proteins (2) Poor (2) Mice (2) Inflammation (2) Grammar, Comparative and general--Case (2) Families (2) Evidence (2) Cells (2) Case (2) Cases (2)

Documents écrit par Y. Banz (7) | parle de Y. Banz (0)

Blinatumomab in Relapsed/Refractory Burkitt Lymphoma.
J. Bohler et al. (21 déc. 2022)
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.
G. Bombaci et al.
Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.
S. Berezowska et al. (18 mai 2021)
Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune Diseases.
S. Porubsky et al. (16 janv. 2021)
Advancing synoptic cancer reports beyond English: the University of Bern/PathoLink approach.
Y. Banz et al.
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.
D. Zysset et al. (20 oct. 2016)
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.
M. Juilland et al. (2016)